These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9166572)

  • 1. US imaging and color Doppler in patients undergoing inhibitory therapy with calcitriol for secondary hyperparathyroidism.
    Pretolesi F; Silvestri E; Di Maio G; Martinoli C; Onetto F; Sala P; Derchi LE
    Eur Radiol; 1997; 7(5):721-5. PubMed ID: 9166572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presurgical setting of secondary hyperparathyroidism using high-resolution sonography and color Doppler.
    Meola M; Petrucci I; Calliada F; Barsotti M; Puccini M; Grosso M; Barsotti G
    Ultraschall Med; 2011 Jan; 32 Suppl 1():S74-82. PubMed ID: 20414855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of intravenous calcitriol therapy on the control of secondary hyperparathyroidism.
    Malberti F; Corradi B; Cosci P; Calliada F; Marcelli D; Imbasciati E
    Am J Kidney Dis; 1996 Nov; 28(5):704-12. PubMed ID: 9158208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between total mass and blood supply of parathyroid glands and their secretion of parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism.
    Ahmadi F; Aghajanzadeh P; Yazdi HR; Maziar S; Gatmiri SM
    Saudi J Kidney Dis Transpl; 2016 Mar; 27(2):263-9. PubMed ID: 26997379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of healing of secondary hyperparathyroidism in chronically hemodialyzed uremic patients treated with long-term intravenous calcitriol.
    Cannella G; Bonucci E; Rolla D; Ballanti P; Moriero E; De Grandi R; Augeri C; Claudiani F; Di Maio G
    Kidney Int; 1994 Oct; 46(4):1124-32. PubMed ID: 7861707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial evaluation of parathyroid size by ultrasonography is another useful marker for the long-term prognosis of calcitriol pulse therapy in chronic dialysis patients.
    Fukagawa M; Kitaoka M; Yi H; Fukuda N; Matsumoto T; Ogata E; Kurokawa K
    Nephron; 1994; 68(2):221-8. PubMed ID: 7830860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term (3 years) prognosis of parathyroid function in chronic dialysis patients after percutaneous ethanol injection therapy guided by colour Doppler ultrasonography.
    Tanaka R; Kakuta T; Fujisaki T; Tanaka S; Sakai H; Kurokawa K; Saito A
    Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():iii58-61. PubMed ID: 12771303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of functioning parathyroid cell mass by ethanol injection in chronic dialysis patients.
    Kitaoka M; Fukagawa M; Ogata E; Kurokawa K
    Kidney Int; 1994 Oct; 46(4):1110-7. PubMed ID: 7861705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of blood supply to the parathyroid glands in secondary hyperparathyroidism compared with histopathology.
    Onoda N; Kurihara S; Sakurai Y; Owada K; Osono E; Adachi H; Suga M; Yoneshima H
    Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():iii34-7. PubMed ID: 12771297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [MIBI and parathyroid gland function in secondary hyperparathyroidism].
    Martín F; Sarró F; Verdú J; González A; Martínez F
    Nefrologia; 2004; 24(4):344-50. PubMed ID: 15455494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effect of intravenous calcitriol on the treatment of severe hyperparathyroidism, parathyroid gland mass and bone mineral density in haemodialysis patients.
    Huraib S; Abu-Aisha H; Abed J; Al Wakeel J; Al Desouki M; Memon N
    Am J Nephrol; 1997; 17(2):118-23. PubMed ID: 9096441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of percutaneous calcitriol injection therapy on secondary hyperparathyroidism in uraemic patients.
    Shiizaki K; Negi S; Mizobuchi M; Hatamura I; Narukawa N; Sakaguchi T; Kitabata Y; Sumikado S; Akizawa T
    Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():iii42-6. PubMed ID: 12771299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcitriol pulse therapy and histology of parathyroid glands in hemodialysis patients.
    Lomonte C; Martino R; Selvaggiolo M; Bona RM; Cazzato F; Milano R; Chiarulli G; Basile C
    J Nephrol; 2003; 16(5):716-20. PubMed ID: 14733419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth of parathyroid gland in uremic patients on maintenance hemodialysis.
    Kawagishi T; Nishizawa Y; Emoto M; Kawasaki K; Shoji S; Inaba M; Miki T; Morita A; Tabata T; Inoue T
    Miner Electrolyte Metab; 1995; 21(1-3):104-8. PubMed ID: 7565428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [(99m)Tc]-sestamibi parathyroid scintigraphy in chronic haemodialysis patients: static and dynamic explorations.
    Olaizola I; Zingraff J; Heuguerot C; Fajardo L; Léger A; Lopez J; Acuña G; Petraglia A; Alvarez A; Caorsi H; Drüeke T; Ambrosoni P
    Nephrol Dial Transplant; 2000 Aug; 15(8):1201-6. PubMed ID: 10910445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of direct injection of calcitriol into the parathyroid glands in uraemic patients with moderate to severe secondary hyperparathyroidism.
    Nakanishi S; Yano S; Nomura R; Tsukamoto T; Shimizu Y; Shin J; Fukagawa M
    Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():iii47-9. PubMed ID: 12771300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Denosumab and Calcitriol on Severe Secondary Hyperparathyroidism in Dialysis Patients With Low Bone Mass.
    Chen CL; Chen NC; Liang HL; Hsu CY; Chou KJ; Fang HC; Lee PT
    J Clin Endocrinol Metab; 2015 Jul; 100(7):2784-92. PubMed ID: 25955225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of ultrasound to assess the response to therapy for secondary hyperparathyroidism.
    Meola M; Petrucci I; Colombini E; Barsotti G
    Am J Kidney Dis; 2011 Sep; 58(3):485-91. PubMed ID: 21715073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ultrasound parameter-based response to treatment with new drugs for secondary hyperparathyroidism: a retrospective analysis in a single dialysis center].
    Vulpio C; Bossola M; De Gaetano A; Maresca G; Panocchia N; Spada P; Tazza L; Luciani G; Castagneto M
    G Ital Nefrol; 2010; 27(5):527-35. PubMed ID: 20922685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.